We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

PlaqueTec

Cardiovascular Disease is the leading cause of death in the UK, PlaqueTec have developed a Liquid Biopsy System, which allows cardiologists to gain further information from a patient's coronary artery and provide more effective treatment to those affected by the disease.


  • £1,493,593
    raised of £2,100,058 goal
  • Active
    18 Jul 2018
  • 31
    backers
  • 14.89%
    equity offered
  • £12,003,757
    pre-money valuation
  • Syndicate Room
    Platform
  • Medical EIS
View on Syndicate Room businessagent.com may earn a commission from partners

not enough data

The content below is news from around the world relating to @PlaqueTec_UK

The below content is from social media taken from external sites and is not representative of the views of businessagent.com or PlaqueTec.

Twitter feed: @PlaqueTec_UK

Please sign in or register to businessagent.com to comment on this pitch.

Sign In Register

Other pitches in Medical


  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph